Surprise Me!

How AI Is Changing Medicine — Drugs, Diagnosis & the Risk

2026-07-21 2 Dailymotion

In 2025, a drug with both its target and molecule designed entirely by
AI completed human clinical trials. It worked. That's just one of the
things AI is quietly doing inside medicine right now. In Episode 4 of
AI at Work, we go inside healthcare AI — how it reads scans, discovers
drugs, writes clinical notes, and personalises treatment to your biology
— plus the serious risks of bias, hallucination and a wrong diagnosis.

Hosted by Oliver & Olga, with deep-dives from Anastasia & Sophia.

🔍 What you'll learn:
• How AI reads scans and outperforms specialists on specific tasks
• The first fully AI-designed drug that worked in human trials
• How "self-driving labs" are compressing drug timelines from 10+ years to 3–6
• Why ambient AI scribes cut physician burnout from 51.9% to 38.8% in 30 days
• The bias problem: why medical AI can fail minorities and women
• Why AI scribes can hallucinate drug dosages — and what's being done about it
• What medical foundation models and continuous monitoring mean for your future health


🎙️ About AI at Work
A series breaking down how AI is transforming real industries.
Previously: Banking, Insurance, Government. Next: Energy.

🔔 Subscribe: / @dailyaiwizard

💬 What do you want us to cover next? Tell us in the comments.

#AIinHealthcare #MedicalAI #ArtificialIntelligence #DrugDiscovery
#HealthTech #DailyAIWizard

SOURCES
1,247 AI medical devices FDA-authorised Aug 2025; 75%+ radiology — FDA / NCBI / IntuitionLabs, Aug 2025
295 AI/ML medical device 510(k) clearances in 2025 alone — Innolitics, Dec 2025
AI improves radiologist sensitivity 6–8%; pooled sensitivity/specificity mor than 90% in fracture detection — NCBI fracture review 2025
IDx-DR: first FDA-authorised autonomous AI diagnostic — IntuitionLabs / FDA
First fully AI-designed drug (target + molecule) Phase IIa completion, dose-dependent improvement — Drug Target Review Feb 2026; Nature Medicine June 2025
AI drug timelines: 3–6 years potential vs 10+; 80–90% Phase I success vs 40–65% traditional — Lifebit.ai, 2025
Dozens of AI-designed candidates in clinical trials by mid-2025 — ScienceDirect Nov 2025
AlphaFold protein-structure predictions: undruggable targets unlocked — DeepMind / industry
Physicians: 5+ hours EHR per 8 hours scheduled; documentation nearly triples burnout odds — Veradigm Mar 2026 / JAMA studies
Prior authorisation: 13 hours/week, 39 requests/physician/week, 89% say it increases burnout — AMA survey / Definitive HC Mar 2026
Ambient AI scribe (Abridge): burnout 51.9% → 38.8% in 30 days — JAMA Network Open, Oct 2025 (Olson et al.)
8.5% less EHR time, 15%+ less note-composition time — Advisory.com / UChicago Medicine JAMA study, Feb 2026
Aidoc CARE1: first FDA-cleared foundation model, Feb 2025 — IntuitionLabs, Mar 2026
Carnegie Mellon/UPMC $10M CPACE center targeting underserved cancer screening — IntuitionLabs, Nov 2025
EU AI Act: medical AI classified high-risk, mandatory human oversight — EU AI Act 2024
Congress: